45 related items for PubMed ID: 24709846
1. Glomerular disease. Antiproteinuric efficacy of A. manihot superior to losartan.
Carney EF.
Nat Rev Nephrol; 2014 Jun; 10(6):300. PubMed ID: 24709846
[No Abstract] [Full Text] [Related]
2. Wen-Yi and Chinese medicine: Why we need to pay attention?
Xiong Y, Bao L, Ma Y, Zhang L, Qin C, Huang L.
Sci Bull (Beijing); 2024 Jun 15; 69(11):1617-1622. PubMed ID: 38704357
[No Abstract] [Full Text] [Related]
3. Effect of Yanshen No.1 Recipe on the microinflammatory state in patients with chronic kidney disease.
Yuan GD, Wang ZZ, Guo MX, Tan JC.
Asian J Surg; 2024 May 15; 47(5):2366-2367. PubMed ID: 38278730
[No Abstract] [Full Text] [Related]
4. The Effectiveness and Safety of Abelmoschus manihot in Treating IgA Nephropathy: A Systematic Review and Meta-Analysis.
Jia Q, Guo J, Cai Y, Huang W, Zhu Z, Xia C, Guo K, Shang H, Liu Y, Liu W.
Evid Based Complement Alternat Med; 2022 May 15; 2022():9730753. PubMed ID: 36248420
[Abstract] [Full Text] [Related]
5. Total extract of Abelmoschus manihot L. alleviates uric acid-induced renal tubular epithelial injury via inhibition of caspase-8/caspase-3/NLRP3/GSDME signaling.
Ding Z, Zhao J, Wang X, Li W, Chen C, Yong C, Zhu Y, Tian F, Liu L, Yu M, Zhou E, Gu L, Yao C, Gao K.
Front Pharmacol; 2022 May 15; 13():907980. PubMed ID: 36052125
[Abstract] [Full Text] [Related]
6. Molecular Mechanistic Pathways Targeted by Natural Antioxidants in the Prevention and Treatment of Chronic Kidney Disease.
Mohany M, Ahmed MM, Al-Rejaie SS.
Antioxidants (Basel); 2021 Dec 22; 11(1):. PubMed ID: 35052518
[Abstract] [Full Text] [Related]
7. Integrated Network Pharmacology Analysis and Pharmacological Evaluation to Explore the Active Components and Mechanism of Abelmoschus manihot (L.) Medik. on Renal Fibrosis.
Gu L, Hong F, Fan K, Zhao L, Zhang C, Yu B, Chai C.
Drug Des Devel Ther; 2020 Dec 22; 14():4053-4067. PubMed ID: 33061308
[Abstract] [Full Text] [Related]
8. Traditional Uses, Chemical Constituents, Biological Properties, Clinical Settings, and Toxicities of Abelmoschus manihot L.: A Comprehensive Review.
Luan F, Wu Q, Yang Y, Lv H, Liu D, Gan Z, Zeng N.
Front Pharmacol; 2020 Dec 22; 11():1068. PubMed ID: 32973492
[Abstract] [Full Text] [Related]
9. Huangkui Capsule Ameliorates Renal Fibrosis in a Unilateral Ureteral Obstruction Mouse Model Through TRPC6 Dependent Signaling Pathways.
Gu LF, Ge HT, Zhao L, Wang YJ, Zhang F, Tang HT, Cao ZY, Yu BY, Chai CZ.
Front Pharmacol; 2020 Dec 22; 11():996. PubMed ID: 32719603
[Abstract] [Full Text] [Related]
10. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
[Abstract] [Full Text] [Related]
11. Glomerular disease. Antiproteinuric efficacy of A. manihot superior to losartan.
Carney EF.
Nat Rev Nephrol; 2014 Jun 11; 10(6):300. PubMed ID: 24709846
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L, Li P, Xing CY, Zhao JY, He YN, Wang JQ, Wu XF, Liu ZS, Zhang AP, Lin HL, Ding XQ, Yin AP, Yuan FH, Fu P, Hao L, Miao LN, Xie RJ, Wang R, Zhou CH, Guan GJ, Hu Z, Lin S, Chang M, Zhang M, He LQ, Mei CL, Wang L, Chen X.
Am J Kidney Dis; 2014 Jul 11; 64(1):57-65. PubMed ID: 24631042
[Abstract] [Full Text] [Related]
13. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF.
Phytother Res; 2021 Jan 11; 35(1):198-206. PubMed ID: 32716080
[Abstract] [Full Text] [Related]
14. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
[Abstract] [Full Text] [Related]
15. Treatment of chronic kidney disease using a traditional Chinese medicine, Flos Abelmoschus manihot (Linnaeus) Medicus (Malvaceae).
Chen Y, Cai G, Sun X, Chen X.
Clin Exp Pharmacol Physiol; 2016 Feb 11; 43(2):145-8. PubMed ID: 26667396
[Abstract] [Full Text] [Related]
16. [Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].
Chen P, Wan Y, Wang C, Zhao Q, Wei Q, Tu Y, Yin X.
Zhongguo Zhong Yao Za Zhi; 2012 Aug 11; 37(15):2252-6. PubMed ID: 23189729
[Abstract] [Full Text] [Related]
17. Glomerular disease. Antiproteinuric efficacy of A. manihot superior to losartan.
Carney EF.
Nat Rev Nephrol; 2014 Jun 11; 10(6):300. PubMed ID: 24709846
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L, Li P, Xing CY, Zhao JY, He YN, Wang JQ, Wu XF, Liu ZS, Zhang AP, Lin HL, Ding XQ, Yin AP, Yuan FH, Fu P, Hao L, Miao LN, Xie RJ, Wang R, Zhou CH, Guan GJ, Hu Z, Lin S, Chang M, Zhang M, He LQ, Mei CL, Wang L, Chen X.
Am J Kidney Dis; 2014 Jul 11; 64(1):57-65. PubMed ID: 24631042
[Abstract] [Full Text] [Related]
19. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF.
Phytother Res; 2021 Jan 11; 35(1):198-206. PubMed ID: 32716080
[Abstract] [Full Text] [Related]
20. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
